Bio-Rad Laboratories | BIO - Umsatzerlöse

Aktienkurs
278.36
Täglich Wechseln
-0.39 -0.14%
Monatlich
-0.44%
Jährlich
13.48%
Q2 Prognose
257.44




Der Umsatz Veränderung Datum
Abbott USD 11.46B 90M 2025-12
Agilent USD 1.8B 63M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Danaher USD 6.84B 790M 2025-12
General Electric Aerospace USD 11.87B 560M 2025-12
Hologic USD 1.05B 0 2025-12
Illumina USD 1.16B 80M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Merck USD 16.4B 880M 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Quest Diagnostics USD 2.81B 10M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Siemens EUR 19.14B 2.29B 2025-12
Standard Biotools USD 23.8M 4.24M 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Tosoh JPY 256.94B 2.93B 2025-12
Waters USD 932M 132M 2025-12